Sofinnova Partners
Sofinnova et al. invest £1.3m in Synthace
Sofinnova Partners has led a ТЃ1.3m funding round for Synthace, a London-based applied synthetic bioengineering company, alongside a syndicate of angel investors.
Omega Funds leads $10m round for SpineVision
Omega Funds has led a $10m funding round for French medical devices provider SpineVision, which also included investments from two other new backers.
Sofinnova backs Auris Medical with CHF 47.1m
French VC Sofinnova Partners has joined US-based Sofinnova Ventures in a CHF 47.1m funding round for Auris Medical.
Sofinnova et al. invest in MetGen
Sofinnova Partners has led a тЌ2.2m round for Finnish start-up MetGen, with participation from Finnish Industry Investment and Finnvera.
Sofinnova closes seventh fund on €240m
Sofinnova Partners has closed its seventh fund on the vehicle's €240m hard-cap.
Sofinnova closes largest European life sciences fund in years
Sofinnova Partners is due to announce a final close on its seventh life sciences fund in the second week of December, unquote” has learned. Kimberly Romaine reports
Sofinnova Partners lists DBV
Paris-based Sofinnova Partners has listed DBV Technologies, raising €40.5m in the IPO on NYSE Euronext Paris.
Sofinnova and Morningside back NuCana BioMed
Sofinnova Partners has led a series-A round for biopharmaceutical company NuCana BioMed alongside Morningside Ventures and other investors, with financing totaling ТЃ6.74m.
Sofinnova Partners backs Hookipa Biotech
Paris-based Sofinnova Partners has led a €7m series-A financing for biotechnology firm Hookipa Biotech.
Sofinnova leads £6m investment in Mission Therapeutics
Sofinnova Partners has led a ТЃ6m funding round for Cambridge-based drug development company Mission Therapeutics.